Steve Rosenberg
Known title: DirectorCIK: 0001256944
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
TCBI Expected to Beat Q3 Earnings Estimates. Analysts expect Texas Capital Bancshares to report earnings above estimates for the third quarter. This positive outlook comes as the stock trades near a key support level, with an average analyst target of $105.08. The company's trailing P/E ratio stands at 10.6, reflecting current market valuation relative to its earnings.
Transaction History
| CNK | ▲ Buy | Grant | 5,439 | $0 | 6/15/2026 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,670 | $0 | 4/22/2026 | View on chart |
| CNK | ▼ Sell | Gift | 11,900 | $0 | 11/10/2025 | View on chart |
| CNK | ▼ Sell | Gift | 11,900 | $0 | 11/10/2025 | View on chart |
| CNK | ▲ Buy | Grant | 4,200 | $0 | 6/13/2025 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,330 | $0 | 4/23/2025 | View on chart |
| TCBI | ▼ Sell | Gift | 1,631 | $0 | 10/29/2024 | View on chart |
| TCBI | ▼ Sell | Gift | 1,631 | $0 | 10/29/2024 | View on chart |
| CNK | ▼ Sell | Gift | 7,867 | $0 | 8/9/2024 | View on chart |
| CNK | ▼ Sell | Gift | 7,867 | $0 | 8/9/2024 | View on chart |
| TCBI | ▼ Sell | Gift | 2,242 | $0 | 7/29/2024 | View on chart |
| TCBI | ▼ Sell | Gift | 2,242 | $0 | 7/29/2024 | View on chart |
| CNK | ▲ Buy | Grant | 7,364 | $0 | 6/14/2024 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,631 | $0 | 4/24/2024 | View on chart |
| CNK | ▼ Sell | Gift | 8,406 | $0 | 7/10/2023 | View on chart |
| CNK | ▼ Sell | Gift | 8,406 | $0 | 7/10/2023 | View on chart |
| CNK | ▲ Buy | Grant | 7,867 | $0 | 6/15/2023 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,377 | $0 | 4/19/2023 | View on chart |
| CNK | ▼ Sell | Gift | 5,203 | $0 | 7/21/2022 | View on chart |
| CNK | ▼ Sell | Gift | 5,203 | $0 | 7/21/2022 | View on chart |
| CNK | ▲ Buy | Grant | 8,406 | $0 | 6/15/2022 | View on chart |
| TCBI | ▼ Sell | Gift | 1,015 | $0 | 5/25/2022 | View on chart |
| TCBI | ▼ Sell | Gift | 1,015 | $0 | 5/25/2022 | View on chart |
| TCBI | ▲ Buy | Grant | 1,377 | $0 | 4/19/2022 | View on chart |
| CNK | ▼ Sell | Gift | 10,516 | $0 | 7/29/2021 | View on chart |
| CNK | ▼ Sell | Gift | 10,516 | $0 | 7/29/2021 | View on chart |
| CNK | ▼ Sell | Gift | 10,516 | $0 | 7/16/2021 | View on chart |
| CNK | ▼ Sell | Gift | 10,516 | $0 | 7/16/2021 | View on chart |
| CNK | ▼ Sell | Gift | 51,427 | $0 | 12/1/2020 | View on chart |
| CNK | ▼ Sell | Gift | 51,427 | $0 | 12/1/2020 | View on chart |
| CNK | ▼ Sell | Gift | 3,211 | $0 | 7/3/2019 | View on chart |
| CNK | ▼ Sell | Gift | 3,211 | $0 | 7/3/2019 | View on chart |
| CNK | ▼ Sell | Gift | 2,822 | $0 | 7/11/2018 | View on chart |
| CNK | ▼ Sell | Gift | 2,822 | $0 | 7/11/2018 | View on chart |
| CNK | ▼ Sell | Gift | 5,880 | $0 | 8/9/2017 | View on chart |
| CNK | ▼ Sell | Gift | 5,880 | $0 | 8/9/2017 | View on chart |
| CNK | ▼ Sell | Gift | 3,300 | $0 | 4/1/2016 | View on chart |
| CNK | ▼ Sell | Gift | 3,300 | $0 | 4/1/2016 | View on chart |
| CNK | ▼ Sell | Gift | 7,929 | $0 | 4/19/2013 | View on chart |
| CNK | ▼ Sell | Gift | 7,929 | $0 | 4/19/2013 | View on chart |
| CNK | ▼ Sell | Gift | 5,005 | $0 | 12/14/2012 | View on chart |
| CNK | ▼ Sell | Gift | 5,005 | $0 | 12/14/2012 | View on chart |
| CNK | ▼ Sell | Gift | 5,414 | $0 | 4/11/2011 | View on chart |
| CNK | ▼ Sell | Gift | 5,414 | $0 | 4/1/2011 | View on chart |
| CNK | ▼ Sell | Gift | 10,121 | $0 | 4/21/2010 | View on chart |
| CNK | ▼ Sell | Gift | 10,121 | $0 | 4/21/2010 | View on chart |
| CNK | ▼ Sell | Gift | 7,745 | $0 | 4/1/2009 | View on chart |
| CNK | ▼ Sell | Gift | 7,745 | $0 | 4/1/2009 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts
Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts. Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.